Antimicrob Agents Chemother 2001 Apr;45(4):1292-4
Department of Bacteriology, Juntendo University, Tokyo, Japan.
We tested the combined activity of vancomycin and seven beta-lactam
antibiotics against Staphylococcus aureus clinical strain Mu3, which
displays heterogeneous resistance to vancomycin. When combined with
vancomycin, four of the seven tested beta-lactams exhibited an additive
effect at or near their MICs, while all showed an antagonistic effect at
lower, sub-MIC levels. This study implicated the unpredictable nature of
combination therapy of beta-lactams and vancomycin against S. aureus with
reduced susceptibility to vancomycin.